The Asia Pacific In Vitro Toxicity Testing Market would witness market growth of 11.6% CAGR during the forecast period (2022-2028).
The availability of various tools in the biotechnology and bioinformatics divisions for conducting in-silico simulations on animal models is also a factor in industry influence. In addition, the growth of toxicology databases for the in-silico study of various chemicals is expected to drive demand for in-vitro procedures, resulting in industry advancement.
Market stability is projected to be enhanced by significant government research funding combined with clear reimbursement rules to build automated and technically sophisticated lab tests and ex-vivo studies equipment.
To uncover the essential routes and elements of these regulatory mechanisms in the reactions to toxin exposure, in vitro toxicity testing should be based on a thorough knowledge of the physiological processes associated with toxicological endpoints. Based on previous carcinogenicity research, the number of significant pathways is predicted to be in the tens to hundreds.
PMDA is responsible for the management of medicines and medical equipment in Japan. PMDA undertakes scientific assessments of marketing permission applications for pharmaceuticals in collaboration with the Ministry of Health, Labour, and Welfare's Pharmaceutical and Food Safety Bureau to monitor their post-market safety. To set testing standards for medical equipment, the International Organization for Standardization (ISO) rules are employed (FDA, 2016b). The GPMT, Buehler testing and LLNA are all accepted methods for medical device skin sensitization testing. However, comparable non-animal tests for pharmaceuticals and medical devices have yet to be accepted by the PMDA.
The South Korean Pharmaceutical Affairs Act covers a wide range of issues concerning pharmaceuticals in South Korea. Risk and ef?ciency assessments for pharmaceuticals intended for human use are handled by the National Institute of Food and Drug Safety Evaluation, which is part of the Ministry of Food and Drug Safety in South Korea. Remedies, herbal medicines, quasi-drugs, and biological materials applied directly to the skin or mucosae have all been tested for sensitization potential.
The China market dominated the Asia Pacific In Vitro Toxicity Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,771.8 Million by 2028. The Japan market is anticipated to grow at a CAGR of 11% during (2022 - 2028). Additionally, The India market would exhibit a CAGR of 12.3% during (2022 - 2028).
Based on Type, the market is segmented into Absorption, Toxic Substances, and Dose. Based on Technology, the market is segmented into Cell Culture Technologies, High Throughput Technologies, and Toxicogenomics. Based on End User, the market is segmented into Cosmetics & Households Products, Pharmaceuticals Industry, Food Industry, Chemicals, and Industry. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide In Vitro Toxicity Testing Market is Projected to reach USD 37.5 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., General Electric (GE) Co., AstraZeneca PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Acacia Pharma Group Plc, GlaxoSmithKline PLC, Helsinn Healthcare SA., and Heron Therapeutics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Absorption
- Toxic Substances
- Dose
By Technology
- Cell Culture Technologies
- High Throughput Technologies
- Toxicogenomics
By End User
- Cosmetics & Households Products
- Pharmaceuticals Industry
- Food Industry
- Chemicals Industry
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- General Electric (GE) Co.
- AstraZeneca PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Acacia Pharma Group Plc
- GlaxoSmithKline PLC
- Helsinn Healthcare SA.
- Heron Therapeutics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific In Vitro Toxicity Testing Market, by Type
1.4.2 Asia Pacific In Vitro Toxicity Testing Market, by Technology
1.4.3 Asia Pacific In Vitro Toxicity Testing Market, by End User
1.4.4 Asia Pacific In Vitro Toxicity Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific In Vitro Toxicity Testing Market by Type
3.1 Asia Pacific Absorption Market by Country
3.2 Asia Pacific Toxic Substances Market by Country
3.3 Asia Pacific Dose Market by Country
Chapter 4. Asia Pacific In Vitro Toxicity Testing Market by Technology
4.1 Asia Pacific Cell Culture Technologies Market by Country
4.2 Asia Pacific High Throughput Technologies Market by Country
4.3 Asia Pacific Toxicogenomics Market by Country
Chapter 5. Asia Pacific In Vitro Toxicity Testing Market by End User
5.1 Asia Pacific Cosmetics & Households Products Market by Country
5.2 Asia Pacific Pharmaceuticals Industry Market by Country
5.3 Asia Pacific Food Industry Market by Country
5.4 Asia Pacific Chemicals Industry Market by Country
Chapter 6. Asia Pacific In Vitro Toxicity Testing Market by Country
6.1 China In Vitro Toxicity Testing Market
6.1.1 China In Vitro Toxicity Testing Market by Type
6.1.2 China In Vitro Toxicity Testing Market by Technology
6.1.3 China In Vitro Toxicity Testing Market by End User
6.2 Japan In Vitro Toxicity Testing Market
6.2.1 Japan In Vitro Toxicity Testing Market by Type
6.2.2 Japan In Vitro Toxicity Testing Market by Technology
6.2.3 Japan In Vitro Toxicity Testing Market by End User
6.3 India In Vitro Toxicity Testing Market
6.3.1 India In Vitro Toxicity Testing Market by Type
6.3.2 India In Vitro Toxicity Testing Market by Technology
6.3.3 India In Vitro Toxicity Testing Market by End User
6.4 South Korea In Vitro Toxicity Testing Market
6.4.1 South Korea In Vitro Toxicity Testing Market by Type
6.4.2 South Korea In Vitro Toxicity Testing Market by Technology
6.4.3 South Korea In Vitro Toxicity Testing Market by End User
6.5 Singapore In Vitro Toxicity Testing Market
6.5.1 Singapore In Vitro Toxicity Testing Market by Type
6.5.2 Singapore In Vitro Toxicity Testing Market by Technology
6.5.3 Singapore In Vitro Toxicity Testing Market by End User
6.6 Malaysia In Vitro Toxicity Testing Market
6.6.1 Malaysia In Vitro Toxicity Testing Market by Type
6.6.2 Malaysia In Vitro Toxicity Testing Market by Technology
6.6.3 Malaysia In Vitro Toxicity Testing Market by End User
6.7 Rest of Asia Pacific In Vitro Toxicity Testing Market
6.7.1 Rest of Asia Pacific In Vitro Toxicity Testing Market by Type
6.7.2 Rest of Asia Pacific In Vitro Toxicity Testing Market by Technology
6.7.3 Rest of Asia Pacific In Vitro Toxicity Testing Market by End User
Chapter 7. Company Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 General Electric (GE) Co.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 AstraZeneca PLC
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Catalent, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Laboratory Corporation of America Holdings (Covance, Inc.)
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Recent strategies and developments:
7.5.4.1 Acquisition and Mergers:
7.6 Acacia Pharma Group Plc
7.6.1 Company Overview
7.7 GlaxoSmithKline PLC (TESARO, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Helsinn Healthcare SA.
7.8.1 Company Overview
7.9 Heron Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
TABLE 1 Asia Pacific In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Absorption Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Absorption Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Toxic Substances Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Toxic Substances Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Dose Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Dose Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 12 Asia Pacific In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Cell Culture Technologies Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Cell Culture Technologies Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific High Throughput Technologies Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific High Throughput Technologies Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Toxicogenomics Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Toxicogenomics Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 Asia Pacific In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Cosmetics & Households Products Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Cosmetics & Households Products Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Pharmaceuticals Industry Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Pharmaceuticals Industry Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Food Industry Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Food Industry Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Chemicals Industry Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Chemicals Industry Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific In Vitro Toxicity Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific In Vitro Toxicity Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 China In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 32 China In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 33 China In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 34 China In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 35 China In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 36 China In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 37 China In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 38 China In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 39 Japan In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 40 Japan In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 41 Japan In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 42 Japan In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 43 Japan In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 44 Japan In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 45 Japan In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 46 Japan In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 47 India In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 48 India In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 49 India In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 50 India In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 51 India In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 52 India In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 53 India In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 54 India In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 55 South Korea In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 56 South Korea In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 57 South Korea In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 58 South Korea In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 59 South Korea In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 60 South Korea In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 61 South Korea In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 62 South Korea In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 63 Singapore In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 64 Singapore In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 65 Singapore In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 66 Singapore In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 67 Singapore In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 68 Singapore In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 69 Singapore In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 70 Singapore In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 71 Malaysia In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 72 Malaysia In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 73 Malaysia In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 74 Malaysia In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 75 Malaysia In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 76 Malaysia In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 77 Malaysia In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 78 Malaysia In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific In Vitro Toxicity Testing Market, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific In Vitro Toxicity Testing Market, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific In Vitro Toxicity Testing Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific In Vitro Toxicity Testing Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific In Vitro Toxicity Testing Market by Technology, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific In Vitro Toxicity Testing Market by Technology, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific In Vitro Toxicity Testing Market by End User, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific In Vitro Toxicity Testing Market by End User, 2022 - 2028, USD Million
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 KEY INFORMATION – GENERAL ELECTRIC (GE) CO.
TABLE 89 KEY INFORMATION – ASTRAZENECA PLC
TABLE 90 Key information – CATALENT, INC.
TABLE 91 Key Information – Laboratory Corporation of America holdings
TABLE 92 Key Information – Acacia Pharma Group Plc
TABLE 93 Key Information – GlaxoSmithKline PLC
TABLE 94 Key Information – Helsinn Healthcare SA.
TABLE 95 Key Information – Heron Therapeutics, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: thermo fisher scientific, inc.
FIG 3 Swot analysis: General electric (GE) Co.